Clinical Trials Search Results

1 - 10 of 82 Results

Acute Lymphoblastic Leukemia - Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia

Studies how well blinatumomab works compared with standard combination chemotherapy.

DLBCL Relapsed - A Study of Obinutuzumab, Polatuzumab Vedotin, and Venetoclax in Relapsed or Refractory Follicular Lymphoma (FL) or Diffuse Large B-Cell Lymphoma (DLBCL)

Evaluates the safety, efficacy, and pharmacokinetics of induction treatment with obinutuzumab, polatuzumab vedotin, and venetoclax in participants with relapsed or refractory FL or DLBCL.

Ewing's Sarcoma - Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma

Studies how well combination chemotherapy with or without ganitumab works in treating patients.

HER2 Positive BC - Study of Tucatinib vs Placebo With Capecitabine & Trastuzumab in Patients With Advanced HER2+ Breast Cancer

 The purpose of this study is to assess the effect of tucatinib vs. placebo in combination with capecitabine and trastuzumab on progression-free survival (PFS) per RECIST 1.1 based on independent central review.

Learn more at Clinicaltrials.gov NCT02614794

1 - 10 of 82 Results